Sep 2026· Chemical Science· 0 citations· 31 references
Medicine
TL;DR
The design, iterative synthesis, and comprehensive property profiling of a novel chemical library of shape-defined, morpholine-containing pentacycles revealed promising drug-like properties, including broad aqueous solubility, metabolic stability, low cytochrome P450 inhibition, and tunable membrane permeability.
Abstract
Small-molecule drug discovery is increasingly applied to targets historically classified as “undruggable”, such as non-coding RNAs and biomolecular interactions. These complex interfaces demand ligands with greater three-dimensional complexity and preferred physicochemical profiles that are deficient in typical small molecule chemical libraries housed in large pharmaceutical companies or commercial suppliers. Inspired by the need for novel libraries that might hypothetically address these target classes, we report the design, iterative synthesis, and comprehensive property profiling of a novel chemical library of shape-defined, morpholine-containing pentacycles. Utilizing iterative Stannyl Amine Protocol (iSnAP) reagents, we divergently assembled rigid, 3D-diverse scaffolds that exhibit a chameleonic basic character at physiological pH, elegantly balancing aqueous solubility with membrane permeability. Computational analysis of the 2400-member virtual library confirmed that it occupies a distinct, three-dimensional chemical space. Furthermore, high-throughput experimental profiling of the synthesized compounds revealed promising drug-like properties, including broad aqueous solubility, metabolic stability, low cytochrome P450 inhibition, and tunable membrane permeability. Although no bioactivity has yet been discovered from this library, the compounds offer a robust chemical foundation for future evaluations in ligand screenings targeting emerging therapeutic modalities.
This review presents a three-tiered engineering framework that systematically addresses these barriers. First, we survey chemical and sequence-based stabilization strategies, including lipidation, backbone N-methylation, and cyclization, that convert labile natural peptides into protease-resistant scaffolds. Second, mo...
Qi-Jun Xie, Hai-Ying Ma, Biao Liu et al.· Biology· 0 citations
Macrocyclic scaffolds have become increasingly important in modern drug discovery owing to their structural preorganization, favorable pharmacological properties, and widespread incorporation into peptide- and amino acid-based therapeutics. In contrast, the integration of biologically relevant amino acid architectures...
Justin C. Holmes, Ballard C. Smith, Oluwatosin A. Obisesan et al.· Journal of Inorganic Biochem...· 0 citations
In modern drug discovery, significant focus is placed on modulating the physical and biological properties of small molecules to address emerging therapeutic challenges, such as drug resistance and target selectivity. In this context, bicyclic and spiro compounds have gained importance as privileged scaffolds owing to...
S. Ramkumar, S. Bose· Advanced Synthesis & Cat...· 0 citations
Chalcones, pyrazolines, and pyrazoles constitute a uniquely powerful discovery pipeline in which each is a privileged scaffold with distinct applications, while also serving as the synthetic precursor to the next. Despite a theoretical chalcone library exceeding 680 000 unique structures accessible from commercial star...
Alexander Ciupa· RSC Medicinal Chemistry· 0 citations
Peptide lasso-grafting strategies enable the transfer of established pharmacophores into compact protein scaffolds but often require optimization to preserve target binding and biological activity. Here, we report Random in-vitro Protein single-Loop Engineering (RiPLE), an mRNA-display strategy for the direct discovery...
Kilian Colas, T. Ko, G. Philippe et al.· bioRxiv· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.